Fuck Alzheimer's

A new study has revealed that gardens in care homes could provide promising therapeutic benefits for patients suffering from dementia. Read & Research Alzheimer’s More

START therapy reduces anxiety and depression in dementia carersA new study presented at the Alzheimer’s Association International Conference 2014 shows that eight sessions of psychological… Read & Research Alzheimer’s More

The main pathological changes of Alzheimer’s disease (AD) include amyloid-beta protein-induced hippocampal neuronal injury and neurite outgrowth impairment. Read & Research Alzheimer’s More

Judes Poirier, PhD, C.Q., from the Douglas Mental Health Institute and McGill University in Montreal (Canada) and his team have discovered that a relatively frequent genetic variant actually conveys… Read & Research Alzheimer’s More

Taking B vitamins doesn’t slow mental decline as we age, nor is it likely to prevent Alzheimer’s disease, conclude Oxford University researchers who have assembled all the best clinical trial data… Read & Research Alzheimer’s More

Researchers have successfully restored memory and learning deficits in Alzheimer’s mouse models by transplanting healthy brain cells into the hippocampus. Read & Research Alzheimer’s More

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various… Read & Research Alzheimer’s More

Participation in activities that promote mental activity, and moderate physical activity in middle age, may help protect against the development of Alzheimer’s disease and dementia in later life… Read & Research Alzheimer’s More

Four new studies presented at the Alzheimer’s Association International Conference 2014 suggest that eye and smell tests could be used for early detection of Alzheimer’s. Read & Research Alzheimer’s More

Previous research has suggested over half of Alzheimer’s cases are preventable. Now, a study that includes risk factor interaction puts it nearer one in three. Read & Research Alzheimer’s More

Recent evidence has demonstrated that transplantation of mesenchymal stem cells can stimulate neurogenesis in the brain of adult rat or mouse models of Alzheimer’s disease (AD) and improve tissue and… Read & Research Alzheimer’s More

A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer’s disease, according to… Read & Research Alzheimer’s More

A decreased ability to identify odors might indicate the development of cognitive impairment and Alzheimer’s disease, while examinations of the eye could indicate the build-up of beta-amyloid, a… Read & Research Alzheimer’s More

Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists at Rockefeller University have identified a protein that makes breast cancer cells more likely to… Read & Research Alzheimer’s More

Smokers have a 45% higher risk of developing dementia than non-smokers, according to information published by the World Health Organization (WHO) in collaboration with Alzheimer’s Disease… Read & Research Alzheimer’s More

Cholinergic inhibitors and N-methyl-D-aspartate receptor antagonists can alleviate the symptoms of Alzheimer’s disease, but fail to affect irreversible cognitive dysfunction and effectively scavenge… Read & Research Alzheimer’s More

We are now a step closer to having a drug that can cure dementia and memory loss. Read & Research Alzheimer’s More

It may smell of flatulence and have a reputation for being highly toxic, but when used in the right tiny dosage, hydrogen sulfide is now being being found to offer potential health benefits in a… Read & Research Alzheimer’s More

The protein that is mutated in Huntington’s disease is critical for wiring the brain in early life, according to a new Duke University study. Read & Research Alzheimer’s More

The pathogenesis of vascular dementia induced by chronic cerebral ischemia is complex, mainly consisting of energy metabolism disorder, oxidative stress injury, neuronal apoptotic cell death and… Read & Research Alzheimer’s More

In a large study, scientists have taken a step closer to a simple blood test for Alzheimer’s by showing 10 proteins in the blood can predict onset of the disease. Read & Research Alzheimer’s More

Researchers from the Sanders-Brown Center on Aging at the University of Kentucky have been able to confirm anecdotal information on patients with both Alzheimer’s disease (AD) and cerebrovascular… Read & Research Alzheimer’s More

Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer’s disease (AD), revealing an urgent need to increase the… Read & Research Alzheimer’s More

An international team of researchers identified a pathogenic mechanism that is common to several neurodegenerative diseases. Read & Research Alzheimer’s More

Deep inside the brains of people with dementia and Lou Gehrig’s disease, globs of abnormal protein gum up the inner workings of brain cells – dooming them to an early death. Read & Research Alzheimer’s More

A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has identified a chemical “switch” that controls both the generation of new neurons from neural stem cells… Read & Research Alzheimer’s More

The key to fighting brain diseases like dementia and Lou Gehrig’s disease could lie in boosting the inbuilt capacity of brain cells to eat the proteins that clog them up. Read & Research Alzheimer’s More

International experts reach a consensus on a simpler, more reliable way to diagnose Alzheimer’s disease that promises to reduce the current 33% misdiagnosis rate. Read & Research Alzheimer’s More

Persons with reduced levels of the TREM2 protein could be at greater risk of developing neurodegenerative diseases such as Alzheimer’s disease or frontotemporal dementia, according to an… Read & Research Alzheimer’s More

An analysis of clinical trials shows that the pipeline for potential treatments of Alzheimer’s disease (AD) is small and rate of success is limited, according to research published in the open… Read & Research Alzheimer’s More